NASDAQ: OVIDOvid Therapeutics Inc Earnings Dates, Reports, Calls
Ovid Therapeutics earnings were -$25.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest OVID earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$10.2M, up 10.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OVID reported annual earnings of -$26.4M, with -49.5% growth.
OVID earnings history
Current Revenue
$548.0k
Current Earnings
-$25.0M
Current Profit Margin
-4,557.1%
OVID Return on Equity
Current Company
-34.1%
Current Industry
-60.2%
Current Market
31.5%
OVID's Return on Equity (-34.1%)... subscribe to Premium to read more.
High Return on Equity Performance
OVID undefined
Current Company
-25.3%
Current Industry
-2.5%
OVID is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when OVID announces earnings.
OVID undefined
Current Company
-34.52%
Current Industry
5.8%
OVID vs Biotech Stocks
Ovid Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.